Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Vascana Findings To Be Presented At International Scleroderma Conference


  • Please log in to reply
No replies to this topic

#1 Guest_Jude the Grouch_*

Guest_Jude the Grouch_*
  • Guests

Posted 01 June 2007 - 10:37 AM

Vascana Findings To Be Presented At International Scleroderma Conference. The Vascana presentation will focus on its phase III clinical trial results and on MediQuest's proprietary Topical Amphi-Matrix (TAM) drug delivery system. With the TAM technology, Raynaud's patients will be able to apply a non-systemic, topical formulation at the affected area to deliver relief. Medical News Today. 05/19/07. (Also see: Raynaud's Treatments)